Do antiviral drugs metabolized by CYP3A4 interact with oral fluconazole?

Significant Drug Interactions Between Oral Fluconazole and Antiretroviral Drugs

Yes, oral fluconazole has clinically significant interactions with certain antiretroviral drugs, particularly those metabolized by CYP3A4, though the severity varies considerably by specific antiretroviral agent.

Mechanism of Interaction

Fluconazole is a moderate inhibitor of CYP3A4 and CYP2C9, and a strong inhibitor of CYP2C19 1. This enzyme inhibition can increase plasma concentrations of antiretroviral drugs metabolized through these pathways, potentially leading to unexpected toxicity 2. The enzyme-inhibiting effect of fluconazole persists 4-5 days after discontinuation due to its long half-life 1.

Specific Antiretroviral Interactions

Protease Inhibitors (High Risk)

Several HIV protease inhibitors are contraindicated or require extreme caution with fluconazole 3:

• Ritonavir-boosted regimens: Contraindicated with fluconazole, particularly at higher fluconazole doses 3
• Efavirenz, etravirine, nevirapine: Contraindicated with fluconazole 3
• Cobicistat-based regimens: Contraindicated 3

The 2016 IDSA guidelines emphasize that antiretroviral agents have "variable effects" with azoles and note that "monitoring of azole levels recommended, and bidirectional drug-drug interactions common" 4.

Safe Antiretroviral Options

The following antiretrovirals have no significant interactions with fluconazole and can be safely co-administered 3:

• Raltegravir
• Maraviroc
• Rilpivirine
• Tenofovir
• Emtricitabine
• Lamivudine
• Abacavir

Indinavir (Moderate Risk)

Research demonstrates that fluconazole causes a marginally significant decrease in indinavir AUC (area under curve), though the clinical significance remains unclear 5. Indinavir and fluconazole can be administered concomitantly without dose adjustment, though monitoring is prudent 5.

Clinical Management Algorithm

Before initiating fluconazole in patients on antiretroviral therapy:

1. Identify the specific antiretroviral regimen - Check if it contains ritonavir, cobicistat, efavirenz, etravirine, or nevirapine

   • If YES → Fluconazole is contraindicated; consider alternative antifungal (echinocandin or amphotericin B formulation)
   • If NO → Proceed to step 2

2. For protease inhibitor-based regimens without ritonavir/cobicistat:

   • Monitor closely for signs of PI toxicity
   • Consider therapeutic drug monitoring if available
   • The potential for drug interactions should be carefully evaluated before initiation 2

3. For integrase inhibitors or NRTIs (listed above as safe):

   • Fluconazole can be used without dose adjustment
   • Standard monitoring applies

4. Monitor for bidirectional interactions:

   • Antiretrovirals may also affect fluconazole levels 4
   • Consider therapeutic drug monitoring for both agents in complex cases 4

Important Caveats

Fluconazole is generally the preferred azole for HIV patients due to its relatively weak interactive potential compared to other azoles like itraconazole, voriconazole, or posaconazole 6. The FDA drug label explicitly states that fluconazole is a moderate (not strong) CYP3A4 inhibitor, making it safer than ketoconazole or itraconazole in this population 1.

Common pitfall: Assuming all azoles have equal interaction potential. Fluconazole has significantly fewer interactions than other systemic azoles, making it the antifungal of choice when azole therapy is needed in HIV patients on compatible antiretroviral regimens 6.

The 2004 CDC/NIH/IDSA guidelines emphasize that "the potential for drug interactions, particularly with antiretroviral drugs, should be carefully evaluated before initiation of therapy" with any azole 2.